Tech Company Financing Transactions
Madeira Therapeutics Funding Round
Madeira Therapeutics closed a $100 thousand financing round on 9/30/2009. Backers included Kansas Technology Enterprise Corporation.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
4745 W. 136th Street 102
Leawood, KS 66224
USA
Leawood, KS 66224
USA
Phone
Website
Email Address
Overview
We are a drug development company specializing in real pediatric medicine by reformulating compounds currently approved for adults with substantial safety and efficacy and determining an accurate pediatric dosage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Joiner
Chief Scientific Officer
Kenneth Phelps
VP - Bus. Development
Allen Conger
Browse more venture capital transactions:
Prev: 9/30/2009: Rethink Robotics venture capital transaction
Next: 9/30/2009: Metagenics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs